Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950134-02-010259
Filing Date
2002-08-16
Accepted
2002-08-16 10:53:10
Documents
1
Group Members
DAVID EINHORNJEFFREY A KESWIN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G d99251bsc13g.txt SC 13G 17217
  Complete submission text file 0000950134-02-010259.txt   19306
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Subject) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-49690 | Film No.: 02740654
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 420 LEXINGTON AVENUE SUITE 875 NEW YORK NY 10170
Business Address 420 LEXINGTON AVE SUITE 875 NEW YORK NY 10170 2129731900
GREENLIGHT CAPITAL LLC (Filed by) CIK: 0001040272 (see all company filings)

EIN.: 133886851 | State of Incorp.: DE | Fiscal Year End: 1231